PT975640E - Derivados halogenados anti-mitoticos de alcaloides de vinca - Google Patents

Derivados halogenados anti-mitoticos de alcaloides de vinca

Info

Publication number
PT975640E
PT975640E PT98920607T PT98920607T PT975640E PT 975640 E PT975640 E PT 975640E PT 98920607 T PT98920607 T PT 98920607T PT 98920607 T PT98920607 T PT 98920607T PT 975640 E PT975640 E PT 975640E
Authority
PT
Portugal
Prior art keywords
mitotical
anal
vinca alkaloids
halogenated derivatives
formula
Prior art date
Application number
PT98920607T
Other languages
English (en)
Portuguese (pt)
Inventor
Jacques Fahy
Bridget Hill
Alain Duflos
Valerie Thillaye Du Boulay
Jean-Marc Barret
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of PT975640E publication Critical patent/PT975640E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
PT98920607T 1997-04-10 1998-04-10 Derivados halogenados anti-mitoticos de alcaloides de vinca PT975640E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704398A FR2761990B1 (fr) 1997-04-10 1997-04-10 Derives halogenes antimitotiques d'alcaloides de vinca

Publications (1)

Publication Number Publication Date
PT975640E true PT975640E (pt) 2004-11-30

Family

ID=9505731

Family Applications (2)

Application Number Title Priority Date Filing Date
PT98920607T PT975640E (pt) 1997-04-10 1998-04-10 Derivados halogenados anti-mitoticos de alcaloides de vinca
PT06124480T PT1764368E (pt) 1997-04-10 1998-04-10 Derivados halogenados anti-mitóticos de alcalóides de vinca

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT06124480T PT1764368E (pt) 1997-04-10 1998-04-10 Derivados halogenados anti-mitóticos de alcalóides de vinca

Country Status (15)

Country Link
US (1) US6127377A (https=)
EP (3) EP1357125A3 (https=)
JP (3) JP4401440B2 (https=)
AT (2) ATE270297T1 (https=)
AU (1) AU737549C (https=)
BR (2) BR9807944B1 (https=)
CA (3) CA2455416C (https=)
CY (2) CY1111476T1 (https=)
DE (3) DE69841766D1 (https=)
DK (2) DK1764368T3 (https=)
ES (2) ES2347878T3 (https=)
FR (2) FR2761990B1 (https=)
LU (1) LU91769I2 (https=)
PT (2) PT975640E (https=)
WO (1) WO1998045301A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
WO2005055939A2 (en) * 2003-12-04 2005-06-23 Amr Technology, Inc. Vinca derivatives
WO2005055943A2 (en) * 2003-12-04 2005-06-23 Amr Technology, Inc. Vinorelbine derivatives
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
US7772177B2 (en) 2005-05-18 2010-08-10 Aegera Therapeutics, Inc. BIR domain binding compounds
FR2894966B1 (fr) 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
AU2007250443B2 (en) 2006-05-16 2013-06-13 Pharmascience Inc. IAP BIR domain binding compounds
US20080125451A1 (en) * 2006-09-12 2008-05-29 Amr Technology, Inc. Vinorelbine derivatives
US8039453B2 (en) * 2006-09-12 2011-10-18 Albany Molecular Research, Inc. Vinca derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
FR2910812B1 (fr) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
FR2912406B1 (fr) * 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
DE102010020994B4 (de) * 2010-01-27 2022-01-27 Interpane Entwicklungs-Und Beratungsgesellschaft Mbh Verfahren zur Herstellung eines beschichteten Gegenstands mit Texturätzen
WO2011098904A1 (en) 2010-02-12 2011-08-18 Aegera Therapeutics, Inc. Iap bir domain binding compounds
WO2011103007A2 (en) * 2010-02-22 2011-08-25 The Scripps Research Institute 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells
WO2026064527A1 (en) 2024-09-19 2026-03-26 Tesseract Medicines Us, Llc Kras-targeting covalent-induced drug conjugates comprising a tubulin inhibitor payload
WO2026064520A1 (en) 2024-09-19 2026-03-26 Tesseract Medicines Us, Llc Covalent-induced drug conjugates targeting kras and comprising a tubulin inhibitor payload

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707988B1 (fr) * 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca

Also Published As

Publication number Publication date
CA2455416A1 (fr) 1998-10-15
CA2286560A1 (fr) 1998-10-15
CY1111476T1 (el) 2012-01-25
BR9816177B1 (pt) 2010-08-24
EP1764368A1 (fr) 2007-03-21
FR10C0045I1 (https=) 2010-10-29
CA2665949A1 (fr) 1998-10-15
DK0975640T3 (da) 2004-11-01
CA2455416C (fr) 2010-11-02
EP1764368B1 (fr) 2010-07-14
JP2004277418A (ja) 2004-10-07
DE69824840T2 (de) 2005-07-21
JP4307292B2 (ja) 2009-08-05
CA2665949C (fr) 2013-06-11
CY2010019I2 (el) 2012-01-25
JP2001518892A (ja) 2001-10-16
AU7340898A (en) 1998-10-30
PT1764368E (pt) 2010-09-16
CY2010019I1 (el) 2012-01-25
ATE270297T1 (de) 2004-07-15
ATE473987T1 (de) 2010-07-15
CA2286560C (fr) 2009-09-08
EP1357125A3 (fr) 2003-11-26
LU91769I2 (fr) 2011-02-22
AU737549B2 (en) 2001-08-23
ES2347878T3 (es) 2010-11-22
EP1357125A2 (fr) 2003-10-29
JP4401440B2 (ja) 2010-01-20
DE69824840D1 (de) 2004-08-05
EP0975640B1 (fr) 2004-06-30
BR9807944B1 (pt) 2011-02-08
DE69841766D1 (de) 2010-08-26
EP0975640A1 (fr) 2000-02-02
US6127377A (en) 2000-10-03
FR10C0045I2 (fr) 2011-04-29
BR9807944A (pt) 2000-03-08
JP2009167196A (ja) 2009-07-30
DE122010000054I1 (de) 2011-05-05
AU737549C (en) 2002-03-28
ES2222588T3 (es) 2005-02-01
DK1764368T3 (da) 2010-10-18
WO1998045301A1 (fr) 1998-10-15
FR2761990A1 (fr) 1998-10-16
FR2761990B1 (fr) 1999-06-25

Similar Documents

Publication Publication Date Title
LU91769I2 (fr) Ditartrate de Vinflunine.
YU208687A (en) Process for obtaining analog of rebecamicine
CA2335514A1 (en) Alkyl ether analogs of chlorins having an n-substituted imide ring
SE7508332L (sv) Sett att framstella 3-kinolin-karboxylsyraderivat och anvendning derav som lekemedel.
SE9101431D0 (sv) A method for the preparation in a non-racemic form of furo (3,4-c) pyridine derivatives
ES532836A0 (es) Metodo para preparar derivados de acidos b-carbolin-3-barboxilicos
ATE29721T1 (de) 5-(4-vinyl- oder 4-ethynylbenzoyl)-1,2-dihydro-3h-pyrrolo-(1,2-a -pyrrol-1-carbosaeure und deren derivate.
JPS5323993A (en) 7-(n-substituted-2-phenylglycineamido)-3-substituted-3-cephem-4-caroxyli acids
KR870010027A (ko) 벤조티아지논 유도체의 제조 방법
ATE44742T1 (de) Verfahren zur herstellung von ergoline n-methyl- derivaten.
GR852310B (https=)
KR850004760A (ko) 이미다조 퀴놀린 유도체의 제조방법
NO159926C (no) Fremgangsmaate for fremstilling av perfluoralkankarboksylsyrer.
JPS5718680A (en) Indole derivative
KR860006469A (ko) 이미다조 디아제핀 유도체의 제조방법
HUT41393A (en) Process for producing pyridazine derivatives
JPS5246097A (en) Method of preparing pyrrlobenzodiazpins or acid addition salts thereof
JPS51113890A (en) Method for preparing novel cephalosporins
JPS54138600A (en) Benzo-azabicyclo3,3,1-nonane derivative
JPS54148750A (en) Novel halogenoacetanilide derivative and its preparation